In subjects with NAFLD attributable to being overweight and inactive (“Metabolic NAFLD”), the ability of insulin to normally suppress production of glucose and VLDL is impaired [21,22]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.